Harm Reduction Therapeutics
  • Our Story
  • OTC RiVive®
  • Why 3 mg?
  • Contact Us
  • Login
  • My Account
  • Buy Now
  • What Is Harm Reduction
  • Resources
  • News
  • Events
  • FAQ
  • Partner Offerings
  • What Is Harm Reduction?
  • Resources
  • News
  • Events
  • FAQ
  • Partner Offerings
Compassionate Overdose Response Summit Highlights and Key Takeaways

Compassionate Overdose Response Summit Highlights and Key Takeaways

by vcgdeveloper | Aug 27, 2024 | News

Statement Regarding High Dose Naloxone and Long Acting Nalmefene Opioid Overdose Reversal Formulations

Statement Regarding High Dose Naloxone and Long Acting Nalmefene Opioid Overdose Reversal Formulations

by vcgdeveloper | Jul 29, 2024 | News

Exploring Cost and the Emerging Landscape of Naloxone Competition

Exploring Cost and the Emerging Landscape of Naloxone Competition

by vcgdeveloper | Jul 22, 2024 | News

Drug Intervention Institute partners with Harm Reduction Therapeutics to provide low-cost life-saving RiVive™ 3 mg naloxone nasal spray inside ONEbox™

Drug Intervention Institute partners with Harm Reduction Therapeutics to provide low-cost life-saving RiVive™ 3 mg naloxone nasal spray inside ONEbox™

by vcgdeveloper | Mar 1, 2024 | News

Higher naloxone doses have no impact on overdose survival, study shows

Higher naloxone doses have no impact on overdose survival, study shows

by vcgdeveloper | Feb 8, 2024 | News

« Older Entries
  • Contact Us
  • Privacy Policy
  • Accessibility
  • FAQ
  • Follow
  • Follow
  • Follow
  • Follow

© Copyright 2025 Harm Reduction Therapeutics, Inc. All Rights Reserved. To report Adverse Events contact: customercare@harmreductiontherapeutics.org.